Get the latest tech news
FDA Approves Eli Lilly’s GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
None
Or read this on WiredGet the latest tech news
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
None
Or read this on WiredRead more on:
Related news: